Ingevity Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Ingevity wird ein Gewinn- und Umsatzwachstum von 116.9% bzw. 2.3% pro Jahr prognostiziert, während der Gewinn pro Aktie um 116.8% pro Jahr wachsen soll.
Wichtige Informationen
116.9%
Wachstumsrate der Gewinne
116.8%
EPS-Wachstumsrate
| Chemicals Gewinnwachstum | 17.0% |
| Wachstumsrate der Einnahmen | 2.3% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 31 Oct 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
What Ingevity Corporation's (NYSE:NGVT) 32% Share Price Gain Is Not Telling You
Nov 07
Is Ingevity (NYSE:NGVT) A Risky Investment?
Oct 13Ingevity Corporation's (NYSE:NGVT) Prospects Need A Boost To Lift Shares
Sep 08Ingevity: The Risk-Reward Ratio Is Still Unfavorable
Aug 27Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 03Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky
Jul 13Should You Investigate Ingevity Corporation (NYSE:NGVT) At US$45.90?
Jun 14Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?
Apr 18Is Ingevity (NYSE:NGVT) A Risky Investment?
Mar 22What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?
Jan 23Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares
Jan 04These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts
Nov 10Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?
Oct 07Ingevity Corporation: The Risk To Reward Is Currently Favorable
Oct 06Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt
Sep 22Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?
Aug 11Ingevity Corporation: Headwinds Are Temporary
Jul 05Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt
Jun 21Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?
May 29We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt
Feb 16Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?
Jan 25Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate
Sep 13Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?
Aug 22Ingevity to acquire pavement marking materials business Ozark Materials for $325M
Aug 02Ingevity (NYSE:NGVT) Seems To Use Debt Quite Sensibly
Aug 01Ingevity (NYSE:NGVT) Will Want To Turn Around Its Return Trends
Jun 05What Does Ingevity Corporation's (NYSE:NGVT) Share Price Indicate?
May 20Ingevity: Well-Diversified ESG Chemicals Company To Put On Watchlist
May 03We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt
May 02Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 1,540 | 172 | 163 | 278 | 3 |
| 12/31/2025 | 1,451 | 144 | 137 | 247 | 4 |
| 12/31/2024 | 1,414 | -442 | 1 | 112 | 4 |
| 9/30/2024 | 1,479 | -564 | 28 | 110 | N/A |
| 6/30/2024 | 1,548 | -431 | 72 | 169 | N/A |
| 3/31/2024 | 1,640 | -112 | 87 | 188 | N/A |
| 12/31/2023 | 1,692 | -5 | 95 | 205 | N/A |
| 9/30/2023 | 1,704 | 127 | 128 | 257 | N/A |
| 6/30/2023 | 1,740 | 177 | 120 | 252 | N/A |
| 3/31/2023 | 1,678 | 202 | 154 | 294 | N/A |
| 12/31/2022 | 1,668 | 212 | 171 | 313 | N/A |
| 9/30/2022 | 1,621 | 225 | 160 | 291 | N/A |
| 6/30/2022 | 1,516 | 146 | 171 | 291 | N/A |
| 3/31/2022 | 1,454 | 130 | 152 | 266 | N/A |
| 12/31/2021 | 1,392 | 118 | 190 | 293 | N/A |
| 9/30/2021 | 1,381 | 135 | 273 | 370 | N/A |
| 6/30/2021 | 1,336 | 209 | 272 | 360 | N/A |
| 3/31/2021 | 1,248 | 185 | 264 | 343 | N/A |
| 12/31/2020 | 1,216 | 181 | 270 | 352 | N/A |
| 9/30/2020 | 1,194 | 180 | 199 | 285 | N/A |
| 6/30/2020 | 1,222 | 170 | 222 | 313 | N/A |
| 3/31/2020 | 1,304 | 206 | 238 | 344 | N/A |
| 12/31/2019 | 1,293 | 184 | 161 | 276 | N/A |
| 9/30/2019 | 1,268 | 182 | 159 | 276 | N/A |
| 6/30/2019 | 1,219 | 171 | 131 | 252 | N/A |
| 3/31/2019 | 1,175 | 161 | 126 | 234 | N/A |
| 12/31/2018 | 1,134 | 169 | 158 | 252 | N/A |
| 9/30/2018 | 1,085 | 169 | 134 | 207 | N/A |
| 6/30/2018 | 1,037 | 153 | N/A | 193 | N/A |
| 3/31/2018 | 989 | 138 | N/A | 178 | N/A |
| 12/31/2017 | 972 | 127 | N/A | 174 | N/A |
| 9/30/2017 | 954 | 94 | N/A | 187 | N/A |
| 6/30/2017 | 942 | 53 | N/A | 144 | N/A |
| 3/31/2017 | 927 | 45 | N/A | 131 | N/A |
| 12/31/2016 | 908 | 35 | N/A | 128 | N/A |
| 9/30/2016 | 898 | 34 | N/A | 111 | N/A |
| 6/30/2016 | 902 | 64 | N/A | 100 | N/A |
| 3/31/2016 | 919 | 66 | N/A | 92 | N/A |
| 12/31/2015 | 958 | 80 | N/A | 72 | N/A |
| 9/30/2015 | 999 | 99 | N/A | 76 | N/A |
| 6/30/2015 | 1,025 | 115 | N/A | 111 | N/A |
| 3/31/2015 | 1,022 | 121 | N/A | 106 | N/A |
| 12/31/2014 | 1,036 | 129 | N/A | 139 | N/A |
| 12/31/2013 | 980 | 119 | N/A | 137 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: NGVT wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.6%).
Ertrag vs. Markt: NGVT wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: NGVT wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: NGVTDie Einnahmen des Unternehmens (2.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).
Hohe Wachstumseinnahmen: NGVTDie Einnahmen des Unternehmens (2.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von NGVT in 3 Jahren voraussichtlich hoch sein wird